SCHEMBL5731246

SCHEMBL5731246

Cc1nc(N)c2nc(O)n(Cc3ccc4ccccc4c3)c2n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 2/20 0.44
▸ TLR7 Q9NYK1 3/20 0.43
▸ PTPN1 P18031 1/20 0.42
▸ ACHE P22303 1/20 0.41
▸ MC4R P32245 1/20 0.39
▸ MC5R P33032 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ VDR P11473 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ CHKA P35790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730944 0.86 TLR7 (0.55) TLR7ALDH1A1
SCHEMBL5731691 0.83 TLR7 (0.43) TLR7ALDH1A1SMN1; SMN2
SCHEMBL5730974 0.83 TLR7 (0.43) TLR7KMT2AALDH1A1MEN1
SCHEMBL5731373 0.82 TLR7 (0.42) TLR7KMT2AALDH1A1SMN1; SMN2VDR
SCHEMBL5730510 0.82 TLR7 (0.47) TLR7KMT2AALDH1A1SMN1; SMN2MEN1
SCHEMBL5731812 0.82 TLR7 (0.41) TLR7KMT2AALDH1A1SMN1; SMN2HIF1A
SCHEMBL5731978 0.81 KDM4E (0.47) TLR7KMT2AALDH1A1SMN1; SMN2
SCHEMBL4463674 0.80 TLR7 (0.59) TLR7
SCHEMBL5730847 0.80 TLR7 (0.43) FBP1TLR7PTPN1KMT2A
SCHEMBL10309744 0.80 TLR7 (0.40) TLR7KMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1043021-B1 PURINE DERIVATIVES FOR THE TREATMENT OF ALLERGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS DAINIPPON SUMITOMO PHARMA CO (JP) 2006-05-03 — — EP disclosed
EP-0882727-B9 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2005-06-15 — — EP disclosed
EP-0882727-B1 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2004-12-01 — — EP disclosed
US-6376501-B1 INHIBITING OR REGULATING IMMUNE RESPONSE USING PURINE-DERIVED COMPOUND; NON-STEROIDAL COMPOUND JAPAN ENERGY CORPORATION (JP) 2002-04-23 — — US disclosed
EP-1043021-A1 TYPE 2 HELPER T CELL-SELECTIVE IMMUNE RESPONSE SUPPRESSORS Japan Energy Corporation (JP) 2000-10-11 — — EP disclosed
US-6028076-A FOR INDUCING .ALPHA.-INTERFERON IN A PATIENT HAVING HEPATITIS B OR C, BY ADMINISTERING PURINE DERIVATIVE JAPAN ENERGY CORPORATION (JP) 2000-02-22 — — US disclosed
EP-0882727-A1 NOVEL PURINE DERIVATIVES JAPAN ENERGY CORPORATION (JP) 1998-12-09 — — EP disclosed
Send feedback